The global Chondroitin market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). It is usually found attached to proteins as part of a proteoglycan. A chondroitin chain can have over 100 individual sugars, each of which can be sulfated in variable positions and quantities. Chondroitin sulfate is an important structural component of cartilage and provides much of its resistance to compression. Along with glucosamine, chondroitin sulfate has become a widely used dietary supplement for treatment of osteoarthritis.
Global Chondroitin Sulfate key players include SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, etc. Global top five manufacturers hold a share over 25%.
China is the largest market, with a share over 75%, followed by Europe and North America, both have a share over 10%.
In terms of product, Food Grade is the largest segment, with a share over 70%.
This report is a detailed and comprehensive analysis for global Chondroitin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Chondroitin market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Kg), 2020-2031
Global Chondroitin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Kg), 2020-2031
Global Chondroitin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Kg), 2020-2031
Global Chondroitin market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chondroitin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chondroitin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SANXIN, Focus Chem, GGI, Guanglong Biochem, Hengjie Bio-Pharmaceuticals, Huiwen, ISBA, Jiaixng Hengjie, Meitek, Nippon Zoki, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Chondroitin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Food Grade
Pharmaceutical Grade
麻豆原创 segment by Application
Pharmacy
Health Products
Major players covered
SANXIN
Focus Chem
GGI
Guanglong Biochem
Hengjie Bio-Pharmaceuticals
Huiwen
ISBA
Jiaixng Hengjie
Meitek
Nippon Zoki
Pacific Rainbow
Qingdao Green-Extract
QJBCHINA
Runxin Biotechnology
SANXIN GROUP
Shandong Dongcheng
Sioux Pharm
Summit Nutritionals
TSI Group
WanTuMing Biological
Yantai Dongcheng
YBCC
Yibao Group
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chondroitin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chondroitin, with price, sales quantity, revenue, and global market share of Chondroitin from 2020 to 2025.
Chapter 3, the Chondroitin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chondroitin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Chondroitin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chondroitin.
Chapter 14 and 15, to describe Chondroitin sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Chondroitin Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Food Grade
1.3.3 Pharmaceutical Grade
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Chondroitin Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmacy
1.4.3 Health Products
1.5 Global Chondroitin 麻豆原创 Size & Forecast
1.5.1 Global Chondroitin Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Chondroitin Sales Quantity (2020-2031)
1.5.3 Global Chondroitin Average Price (2020-2031)
2 Manufacturers Profiles
2.1 SANXIN
2.1.1 SANXIN Details
2.1.2 SANXIN Major Business
2.1.3 SANXIN Chondroitin Product and Services
2.1.4 SANXIN Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 SANXIN Recent Developments/Updates
2.2 Focus Chem
2.2.1 Focus Chem Details
2.2.2 Focus Chem Major Business
2.2.3 Focus Chem Chondroitin Product and Services
2.2.4 Focus Chem Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Focus Chem Recent Developments/Updates
2.3 GGI
2.3.1 GGI Details
2.3.2 GGI Major Business
2.3.3 GGI Chondroitin Product and Services
2.3.4 GGI Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 GGI Recent Developments/Updates
2.4 Guanglong Biochem
2.4.1 Guanglong Biochem Details
2.4.2 Guanglong Biochem Major Business
2.4.3 Guanglong Biochem Chondroitin Product and Services
2.4.4 Guanglong Biochem Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Guanglong Biochem Recent Developments/Updates
2.5 Hengjie Bio-Pharmaceuticals
2.5.1 Hengjie Bio-Pharmaceuticals Details
2.5.2 Hengjie Bio-Pharmaceuticals Major Business
2.5.3 Hengjie Bio-Pharmaceuticals Chondroitin Product and Services
2.5.4 Hengjie Bio-Pharmaceuticals Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Hengjie Bio-Pharmaceuticals Recent Developments/Updates
2.6 Huiwen
2.6.1 Huiwen Details
2.6.2 Huiwen Major Business
2.6.3 Huiwen Chondroitin Product and Services
2.6.4 Huiwen Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Huiwen Recent Developments/Updates
2.7 ISBA
2.7.1 ISBA Details
2.7.2 ISBA Major Business
2.7.3 ISBA Chondroitin Product and Services
2.7.4 ISBA Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 ISBA Recent Developments/Updates
2.8 Jiaixng Hengjie
2.8.1 Jiaixng Hengjie Details
2.8.2 Jiaixng Hengjie Major Business
2.8.3 Jiaixng Hengjie Chondroitin Product and Services
2.8.4 Jiaixng Hengjie Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Jiaixng Hengjie Recent Developments/Updates
2.9 Meitek
2.9.1 Meitek Details
2.9.2 Meitek Major Business
2.9.3 Meitek Chondroitin Product and Services
2.9.4 Meitek Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Meitek Recent Developments/Updates
2.10 Nippon Zoki
2.10.1 Nippon Zoki Details
2.10.2 Nippon Zoki Major Business
2.10.3 Nippon Zoki Chondroitin Product and Services
2.10.4 Nippon Zoki Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Nippon Zoki Recent Developments/Updates
2.11 Pacific Rainbow
2.11.1 Pacific Rainbow Details
2.11.2 Pacific Rainbow Major Business
2.11.3 Pacific Rainbow Chondroitin Product and Services
2.11.4 Pacific Rainbow Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Pacific Rainbow Recent Developments/Updates
2.12 Qingdao Green-Extract
2.12.1 Qingdao Green-Extract Details
2.12.2 Qingdao Green-Extract Major Business
2.12.3 Qingdao Green-Extract Chondroitin Product and Services
2.12.4 Qingdao Green-Extract Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Qingdao Green-Extract Recent Developments/Updates
2.13 QJBCHINA
2.13.1 QJBCHINA Details
2.13.2 QJBCHINA Major Business
2.13.3 QJBCHINA Chondroitin Product and Services
2.13.4 QJBCHINA Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 QJBCHINA Recent Developments/Updates
2.14 Runxin Biotechnology
2.14.1 Runxin Biotechnology Details
2.14.2 Runxin Biotechnology Major Business
2.14.3 Runxin Biotechnology Chondroitin Product and Services
2.14.4 Runxin Biotechnology Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Runxin Biotechnology Recent Developments/Updates
2.15 SANXIN GROUP
2.15.1 SANXIN GROUP Details
2.15.2 SANXIN GROUP Major Business
2.15.3 SANXIN GROUP Chondroitin Product and Services
2.15.4 SANXIN GROUP Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 SANXIN GROUP Recent Developments/Updates
2.16 Shandong Dongcheng
2.16.1 Shandong Dongcheng Details
2.16.2 Shandong Dongcheng Major Business
2.16.3 Shandong Dongcheng Chondroitin Product and Services
2.16.4 Shandong Dongcheng Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Shandong Dongcheng Recent Developments/Updates
2.17 Sioux Pharm
2.17.1 Sioux Pharm Details
2.17.2 Sioux Pharm Major Business
2.17.3 Sioux Pharm Chondroitin Product and Services
2.17.4 Sioux Pharm Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Sioux Pharm Recent Developments/Updates
2.18 Summit Nutritionals
2.18.1 Summit Nutritionals Details
2.18.2 Summit Nutritionals Major Business
2.18.3 Summit Nutritionals Chondroitin Product and Services
2.18.4 Summit Nutritionals Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 Summit Nutritionals Recent Developments/Updates
2.19 TSI Group
2.19.1 TSI Group Details
2.19.2 TSI Group Major Business
2.19.3 TSI Group Chondroitin Product and Services
2.19.4 TSI Group Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.19.5 TSI Group Recent Developments/Updates
2.20 WanTuMing Biological
2.20.1 WanTuMing Biological Details
2.20.2 WanTuMing Biological Major Business
2.20.3 WanTuMing Biological Chondroitin Product and Services
2.20.4 WanTuMing Biological Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.20.5 WanTuMing Biological Recent Developments/Updates
2.21 Yantai Dongcheng
2.21.1 Yantai Dongcheng Details
2.21.2 Yantai Dongcheng Major Business
2.21.3 Yantai Dongcheng Chondroitin Product and Services
2.21.4 Yantai Dongcheng Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.21.5 Yantai Dongcheng Recent Developments/Updates
2.22 YBCC
2.22.1 YBCC Details
2.22.2 YBCC Major Business
2.22.3 YBCC Chondroitin Product and Services
2.22.4 YBCC Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.22.5 YBCC Recent Developments/Updates
2.23 Yibao Group
2.23.1 Yibao Group Details
2.23.2 Yibao Group Major Business
2.23.3 Yibao Group Chondroitin Product and Services
2.23.4 Yibao Group Chondroitin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.23.5 Yibao Group Recent Developments/Updates
3 Competitive Environment: Chondroitin by Manufacturer
3.1 Global Chondroitin Sales Quantity by Manufacturer (2020-2025)
3.2 Global Chondroitin Revenue by Manufacturer (2020-2025)
3.3 Global Chondroitin Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Chondroitin by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Chondroitin Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Chondroitin Manufacturer 麻豆原创 Share in 2024
3.5 Chondroitin 麻豆原创: Overall Company Footprint Analysis
3.5.1 Chondroitin 麻豆原创: Region Footprint
3.5.2 Chondroitin 麻豆原创: Company Product Type Footprint
3.5.3 Chondroitin 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Chondroitin 麻豆原创 Size by Region
4.1.1 Global Chondroitin Sales Quantity by Region (2020-2031)
4.1.2 Global Chondroitin Consumption Value by Region (2020-2031)
4.1.3 Global Chondroitin Average Price by Region (2020-2031)
4.2 North America Chondroitin Consumption Value (2020-2031)
4.3 Europe Chondroitin Consumption Value (2020-2031)
4.4 Asia-Pacific Chondroitin Consumption Value (2020-2031)
4.5 South America Chondroitin Consumption Value (2020-2031)
4.6 Middle East & Africa Chondroitin Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Chondroitin Sales Quantity by Type (2020-2031)
5.2 Global Chondroitin Consumption Value by Type (2020-2031)
5.3 Global Chondroitin Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Chondroitin Sales Quantity by Application (2020-2031)
6.2 Global Chondroitin Consumption Value by Application (2020-2031)
6.3 Global Chondroitin Average Price by Application (2020-2031)
7 North America
7.1 North America Chondroitin Sales Quantity by Type (2020-2031)
7.2 North America Chondroitin Sales Quantity by Application (2020-2031)
7.3 North America Chondroitin 麻豆原创 Size by Country
7.3.1 North America Chondroitin Sales Quantity by Country (2020-2031)
7.3.2 North America Chondroitin Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Chondroitin Sales Quantity by Type (2020-2031)
8.2 Europe Chondroitin Sales Quantity by Application (2020-2031)
8.3 Europe Chondroitin 麻豆原创 Size by Country
8.3.1 Europe Chondroitin Sales Quantity by Country (2020-2031)
8.3.2 Europe Chondroitin Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Chondroitin Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Chondroitin Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Chondroitin 麻豆原创 Size by Region
9.3.1 Asia-Pacific Chondroitin Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Chondroitin Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Chondroitin Sales Quantity by Type (2020-2031)
10.2 South America Chondroitin Sales Quantity by Application (2020-2031)
10.3 South America Chondroitin 麻豆原创 Size by Country
10.3.1 South America Chondroitin Sales Quantity by Country (2020-2031)
10.3.2 South America Chondroitin Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Chondroitin Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Chondroitin Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Chondroitin 麻豆原创 Size by Country
11.3.1 Middle East & Africa Chondroitin Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Chondroitin Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Chondroitin 麻豆原创 Drivers
12.2 Chondroitin 麻豆原创 Restraints
12.3 Chondroitin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Chondroitin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Chondroitin
13.3 Chondroitin Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Chondroitin Typical Distributors
14.3 Chondroitin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
SANXIN
Focus Chem
GGI
Guanglong Biochem
Hengjie Bio-Pharmaceuticals
Huiwen
ISBA
Jiaixng Hengjie
Meitek
Nippon Zoki
Pacific Rainbow
Qingdao Green-Extract
QJBCHINA
Runxin Biotechnology
SANXIN GROUP
Shandong Dongcheng
Sioux Pharm
Summit Nutritionals
TSI Group
WanTuMing Biological
Yantai Dongcheng
YBCC
Yibao Group
听
听
*If Applicable.
